2026 Program Committee

Carolina Alarco
Founder and Principal
BioStrategy Advisors

Mara Aspinall
Partner
Illumina Ventures

Abigail Barrow
Managing Partner
Cambridge Innovation Partners

John Billington
Vice President, Global Government Affairs
Shionogi Inc.

Karen Boezi
Board Member, Acrigen Biosciences, Inc.

Hemmie Chang
Boston Office Managing Partner
Arnold & Porter

Sadhana Chitale

Senior Director, Life Sciences, Technology Transfer
New York University Langone Health

Drew Cutshaw
Principal
Pappas Capital

John Craighead
CEO
Syntax Bio

Lori Ellis
Host for ODS

Rolondo Enoch
Director, Head of Diversity and Inclusion in Clinical Trials
Kite Pharma, A Gilead Company

Jack Florio
Managing Director
IPL Capital Advisory

Greg Frank
Director, Global Public Policy
Merck

Elizabeth Franklin
Head, US Public Affairs and Patient Advocacy, Oncology and Neurology
Sanofi

Gail Gannon
CEO
Ensante & Founding Director of the Neurotech Collider Lab
University of California, Berkeley

Luba Greenwood
CEO
Gallop Oncology

Troy Groetken
Shareholder and Board Member
McAndrews, Held & Malloy, Ltd.

Anjali Gupta
CEO & Co-Founder
ANYg.BIO

Mary Haak-Frednscho
Board Member
Surrozen, Inc.

Susie Harborth
Founder
Inspira Fund

Danielle Helton Corwin
Therapeutic Area Head – Neurology
Dompe

Christina Hochul
Director, Government Affairs and Policy
Astellas

Beth Hoffman
President & CEO
Origami Therapeutics

Nancy Hong
Managing Partner
HiTide Venture Capital 

Amy House
VP Corporate Development and Communications
Beacon Therapeutics

Matthew Hudes
CEO
bdlBiologx

Ashley John
Director, Issue Advocacy
Novartis

Rasika Kalamegham
Head, US Regulatory Policy
Genentech

Ravi Kiron
Managing Director
Biopharm Strategy

Andrew Lam
Managing Director, Head of Biotech Private Equity
Ally Bridge Group

Gabriela Lavezzari
Sr. Director, Digital Transformation and Innovation
GSK

Chris LeMasters
CEO
XinThera, a Gilead Company

Stanley Lewis
Founder and CEO
A28 Therapeutics

Michelle Linn
Founder & CEO
Linnden Communications

Stanley Maloy
Emeritus Associate VP for Innovation and Professor of Microbiology
San Diego State University

Andrew McCandlish
Chief Operating Officer
Revagenix, Inc.

Janet McNicholas
Chief Legal Officer
Invenra

Kevin E. Noonan, Ph.D.
Partner
McDonnell Boehnen Hulbert & Berghoff LLP

Darren Platt
Chief Data Officer
Montage Bio

Daryl Pritchard
SVP, Policy and Government Affairs
Personalized Medicine Coalition

Suguna Rachakonda
VP, Head of Business Development
Insilico Medicine

Michael Rice
Senior Vice President, Expert Advisor, Cell and Gene Therapy
Lumanity

Beth Rogozinski
CEO
Oncoustics AI

Jim Schaeffer
Co-Founder and Chief Business Officer
PhenoTarget Biosciences

Elizabeth Schwarzbach
Chief Business Officer
BigHat Biosciences

Maude Tessier
COO
Hillstar Bio

Lauren Tobe
Director, Regulatory Policy
Eli Lilly

Pam Traxel
Senior Vice President
ACS CAN

Arda Ural
America’s Life Science Sector Leader
Ernst & Young (EY)

Sarah Walinsky
Director, Regulatory Policy and Intelligence
Novartis

Amy Walker
Director, US Policy and Advocacy
CSL Seqirus